The group's principle activity is to provide human umbilical cord blood stem cells and the associated tools and technologies. The group's products include Multi-Lineage Progenitor Cell(TM), PrepaCyte(R) - CB, ActiCyte(R), VitaLyse(R) and MLPC FAQs. The group operates from United States.